Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep930 | Adrenal and Cardiovascular Endocrinology | ECE2024

Silent yet aggressive: a case of large adrenocortical carcinoma with asymptomatic hypercortisolism

Larisa Robu , Beatrice Blesneac Ilona , Tarcau Otilia , Matei Anca , Teodoriu Laura , Florescu Alexandru , Preda Cristina

Introduction: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy arising from the adrenal cortex often with unexpected biological behavior. It can occur at any age, with two peaks of incidence: in the first and between fifth and seventh decades of life. Although ACC are mostly hormonally active, precursors and metabolites may be also produced by dedifferentiated and immature malignant cells.Case report: We report a rare and challenging case of...

ea0099ep348 | Calcium and Bone | ECE2024

Pediatric case of autosomal dominant hypocalcaemia type 2 (ADH2) due to GNA11 gene mutation

Akad Nada , Christina Ungureanu Maria , Tofan Ana , Vasiliu Ioana , Tarcau Otilia-Andreea

Introduction: Autosomal Dominant Hypocalcemia (ADH) presents with low calcium and high phosphorus levels due to hypoparathyroidism. It is categorized into type 1, resulting from gain-of-function mutations in the calcium-sensing receptor (CASR), and type 2, caused by activating mutations in GNA11, a key mediator in CASR signaling. Our contribution involves reporting a rare case of pediatric ADH 2.Case presentation: We present the case of a 9-year-old boy ...

ea0099ep647 | Reproductive and Developmental Endocrinology | ECE2024

Beyond the chromosomal tale: hyperandrogenism in turner syndrome patients

Stafie Ingrid-Ioana , Bilha Stefana , Tarcau Otilia-Andreea , Matei Anca , Leustean Letitia , Preda Cristina

Introduction: Turner syndrome (TS) is a chromosomal disorder that arises due to the complete or partial loss of one sex chromosome, impacting approximately 1 in every 2500 to 3000 female births. The phenotype is attributed to haploinsufficiency of genes on the X chromosome, which are resistant to inactivation. Virilizing symptoms appearing in a patient with TS advocates for an endocrine assessment and karyotyping to ascertain the virilization’s etiology, enabling prompt i...

ea0099ep975 | Reproductive and Developmental Endocrinology | ECE2024

Male hypogonadism: an often overlooked consequence of substance use

Blesneac Ilona-Beatrice , Nita Diana , Tarcau Otilia-Andreea , Larisa Robu , Rosu Andreea , Matei Anca , Florescu Alexandru , Preda Cristina

Introduction: Western countries present a gradual decline in male reproductive function. The decline in testosterone levels and sperm production witnessed over the past five decades, has been ascribed to environmental factors and unhealthy behaviors. Substance and drug usage is recognized as a detrimental lifestyle choice, that can interfere with the processes of steroidogenesis and spermatogenesis. Hypogonadism due to substance and drug abuse can be reversible.<p class="a...

ea0099ep1160 | Endocrine-Related Cancer | ECE2024

MEN2A – unexplored, remains undiscovered

Tarcau Otilia-Andreea , Larisa Robu , Blesneac Ilona-Beatrice , Stafie Ingrid-Ioana , Manaila Maria , Akad Nada , Matei Anca , Christina Ungureanu Maria , Alexandru Grigorovici , Gheorghe Liliana , Delia Ciobanu Gabriela , Florescu Alexandru , Preda Cristina

Introduction: Multiple endocrine neoplasia type 2A is an autosomal dominant disorder, caused by mutations in the RET proto-oncogene. The genetic testing may help us in the early identification of carriers, and it can guide us on the follow-up and on the treatment. Thus, we can significantly reduce the morbidity and mortality of this syndrome. We will illustrate a case and highlight the importance of follow-up in a MEN2A patient.Case report: A 41-year-old...